non-steroidal anti-inflammatory drugs in COVID-19 (hospitalized or not) - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Park, 2021 1.35 [0.63; 2.89]
1.35 [0.63 ; 2.89 ] Park, 2021 1 0% 794 NA not evaluable deathsdetailed results Abu Esba LC (any NSAID use, acute and chronic), 2020 0.49 [0.18; 1.36]
Lund, 2020 1.02 [0.57; 1.82]
Park, 2021 1.33 [0.62; 2.84]
Rinott, 2020 1.22 [0.32; 4.60]
Wong (OpenSAFELY) (Study 1: General population, any NSAID), 2020 0.95 [0.80; 1.13]
0.96 [0.82 ; 1.12 ] Abu Esba LC (any NSAID use, acute and chronic), 2020, Lund, 2020, Park, 2021, Rinott, 2020, Wong (OpenSAFELY) (Study 1: General population, any NSAID), 2020 5 0% 2,820 NA not evaluable deaths (time to event analysis only)detailed results Park, 2021 1.33 [0.62; 2.84]
1.33 [0.62 ; 2.84 ] Park, 2021 1 0% 794 NA not evaluable hospitalizationdetailed results Abu Esba LC (any NSAID use, acute and chronic), 2020 1.54 [1.06; 2.24]
Gianfransesco, 2020 0.64 [0.39; 1.06]
Lund, 2020 1.16 [0.87; 1.54]
1.08 [0.71 ; 1.65 ] Abu Esba LC (any NSAID use, acute and chronic), 2020, Gianfransesco, 2020, Lund, 2020 3 74% 2,064 NA not evaluable mechanical ventilationdetailed results Abu Esba LC (any NSAID use, acute and chronic), 2020 0.92 [0.48; 1.75]
Lund, 2020 1.14 [0.56; 2.31]
Park, 2021 1.61 [0.52; 4.97]
Rinott, 2020 0.93 [0.43; 2.01]
1.05 [0.71 ; 1.53 ] Abu Esba LC (any NSAID use, acute and chronic), 2020, Lund, 2020, Park, 2021, Rinott, 2020 4 0% 2,811 NA not evaluable mechanical ventilation (time to event analysis only)detailed results Park, 2021 1.60 [0.51; 5.06]
1.60 [0.51 ; 5.06 ] Park, 2021 1 0% 794 NA not evaluable ICU admissiondetailed results Lund, 2020 1.04 [0.54; 2.01]
Rinott, 2020 1.42 [0.49; 4.10]
1.13 [0.65 ; 1.99 ] Lund, 2020, Rinott, 2020 2 0% 1,515 NA not evaluable severe COVID-19 occurrencedetailed results Abu Esba LC (any NSAID use, acute and chronic), 2020 0.73 [0.34; 1.56]
0.73 [0.34 ; 1.56 ] Abu Esba LC (any NSAID use, acute and chronic), 2020 1 0% 503 NA not evaluable 0.5 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-07-03 05:25 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 87
- treatments: 668,753,752,836
- roots T: 290
